Plasma advanced glycation end-products and skin autofluorescence are increased in COPD

Gopal Poornima, Reynaert Niki L., Scheijen Jean L.J.M., Engelen Lean, Schalkwijk Casper G., Franssen Frits M.E., Wouters Emiel F.M., Rutten Erica P.A.

Source: Eur Respir J 2014; 43: 430-438
Journal Issue: February
Disease area: Airway diseases

Congress or journal article abstractFull text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Gopal Poornima, Reynaert Niki L., Scheijen Jean L.J.M., Engelen Lean, Schalkwijk Casper G., Franssen Frits M.E., Wouters Emiel F.M., Rutten Erica P.A.. Plasma advanced glycation end-products and skin autofluorescence are increased in COPD. Eur Respir J 2014; 43: 430-438

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Reduced soluble receptor for advanced glycation end-products in COPD
Source: Eur Respir J 2011; 37: 516-522
Year: 2011



Measures of lung function and their relationship with advanced glycation end-products
Source: ERJ Open Res, 6 (2) 00356-2019; 10.1183/23120541.00356-2019
Year: 2020



Anti-tumorigenic effect of age-/diabetes-related advanced glycation end-products in lung carcinoma
Source: Annual Congress 2012 - New biomarkers for lung cancer
Year: 2012


Advanced glycation endproducts are increased in lung tissue from patients with chronic obstructive pulmonary disease
Source: Annual Congress 2008 - Basic science in asthma and COPD
Year: 2008

Late Breaking Abstract - Increased advanced glycation end-products (AGEs) accumulation in skin is a risk factor lung function deterioration in asthmatic patients- preliminary data
Source: International Congress 2019 – Modelling and monitoring of airway diseases
Year: 2019

Soluble RAGE is deficient in neutrophilic asthma and COPD
Source: Eur Respir J 2012; 39: 721-729
Year: 2012



Soluble receptor for advanced glycation end products (sRAGE) in asthmatic children as a new marker of the disease control
Source: Virtual Congress 2021 – Biomarkers and risk factors in childhood asthma
Year: 2021


Loss of receptor for advanced glycation end products (RAGE) in idiopathic pulmonary fibrosis
Source: Annual Congress 2007 - Recent advances in the understanding of lung injury and repair
Year: 2007


Importance of the receptor for advanced glycation end products in the respiratory mechanics
Source: Annual Congress 2012 - Cell culture and animal models of lung disease
Year: 2012

Receptor for advanced glycation end-products and environmental exposure related obstructive airways disease: a systematic review
Source: Eur Respir Rev, 28 (151) 180096; 10.1183/16000617.0096-2018
Year: 2019



A role of the advanced glycation end products (AGEs) in epithelial-myofibroblast transition
Source: Annual Congress 2010 - Experimental approaches in pulmonary fibrosis
Year: 2010

Advanced glycation endproducts (AGE) contribute to the expression of pro-fibrotic cytokines and collagen production in a cell type dependent manner
Source: Eur Respir J 2006; 28: Suppl. 50, 823s
Year: 2006

Associations between plasma sRAGE, esRAGE and AGEs in COPD
Source: Annual Congress 2013 –Environmental and occupational respiratory diseases: new exposure assessment methods, experimental exposure in animal and humans and mechanisms
Year: 2013

Advanced glycation end products and its soluble receptor (sRAGE) are increased in chronic heart failure but not in chronic obstructive pulmonary disease
Source: Annual Congress 2012 - COPD is not a pulmonary disease alone
Year: 2012


Advanced glycation endproducts and lung function in COPD
Source: International Congress 2014 – Best posters in chronic care
Year: 2014


Increased expression of receptor for advanced glycation end products in COPD
Source: International Congress 2014 – Translational studies in COPD
Year: 2014


Advanced glycation end product (AGE), soluble receptor for AGE (sRAGE) and inflammation in smokers and mild/moderate chronic obstructive pulmonary disease (COPD)
Source: International Congress 2015 – Functional capacity, exercise and pulmonary rehabilitation in chronic lung diseases
Year: 2015

Decreased circulatory receptor for advanced glycation end-products is associated with poorer survival in patients with idiopathic pulmonary fibrosis
Source: International Congress 2014 – ILDs 1
Year: 2014

Plasma levels of soluble RAGE are lower in COPD
Source: Annual Congress 2009 - COPD and asthma - from the cell to the clinic
Year: 2009


Signalling through the receptor for advanced glycation end products (RAGE) is increased in acute asthma and correlates with symptom severity
Source: International Congress 2016 – What's new in biomarker analysis?
Year: 2016